Transcriptomic and epigenomic signatures distinguish high- and low-risk endotypes for liver tumor development.
Transcriptomic and epigenomic signatures distinguish high- and low-risk endotypes for liver tumor development. Environ Mol Mutagen. 2024 Nov; 65(9):351-359.